Recruiting NA Sarcopenia in Elderly

New treatment option for Sarcopenia in Elderly

Official title The Effects of MediDrink Platinum+ and Fava Bean Protein Hydrolysate on Fitness in an Aged Population

ClinicalTrials.gov ID: NCT07322653

What this study is testing

What it's testing
Examining the effects of MediDrink Platinum+ containing novel protein blend SRP-01 alone or when combined with PeptiStrong on clinical responses in elderly adults with sarcopenia
  • Which group you join is decided by chance.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 60 and older

You may be able to join if

  • 60 years or older
  • BMI ≤ 25 kg/m²
  • Malnourished (mini nutritional assessment MNA \<11
  • Sarcopenic: SARC-F score ≥ 4
  • Capable or oral feeding either alone or assisted

You likely can't join if

  • Patient cannot eat orally
  • Acute Infection
  • Proven Intestinal obstruction
  • Co-morbidities requiring a special diet (diabetes, kidney disease etc.)
  • Liver dysfunction
  • Acute or chronic renal failure
See the full eligibility criteria
Who can join
  • 60 years or older
  • BMI ≤ 25 kg/m²
  • Malnourished (mini nutritional assessment MNA \<11
  • Sarcopenic: SARC-F score ≥ 4
  • Capable or oral feeding either alone or assisted
  • Ambulatory (WHO PS/ECOG 0-3)
  • Ability to complete questionnaires and self assess health status
  • Ability to provide consent
What rules you out
  • Patient cannot eat orally
  • Acute Infection
  • Proven Intestinal obstruction
  • Co-morbidities requiring a special diet (diabetes, kidney disease etc.)
  • Liver dysfunction
  • Acute or chronic renal failure
  • Uncontrollable nausea or vomiting
  • Use of megestrol acetate or metabolic steroids
  • Dietary supplement use in the last 3 months
  • Known intolerance or allergy to the investigational products
  • Participation in any clinical trial within the last 3 months

The study team makes the final eligibility decision.

Where it's taking place

  • Budapest, Hungary
  • Nyíregyháza, Hungary

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 60 years and older. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Budapest, Hungary; Nyíregyháza, Hungary. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.